NFDA: China has become the world’s second largest market for pharmaceuticals and is the largest exporter of bulk drugs

According to an NFDA official, China produces nearly 5,000 drug raw materials (APIs) providing an annual income of over 2.5 trillion yuan. Cose to 50 pharmaceutical companies are certified by European and American agencies and export APIs for over 13.5 billion US$. Problems to be solved are excess product production capacity caused by low-cost competition, export tax rebates, the pressure of RMB appreciation, and lack of extension of the value chain within China.

China Bio news release, July 13, 2017

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny